Amid uncertainty over how the Trump administration would approach mRNA COVID-19 vaccines for the upcoming respiratory virus season, the FDA has approved updated shots from Pfizer and Moderna. But ...
The Trump administration’s dramatic reworking of U.S. public-health agencies’ approach to vaccines is creating a difficult and unpredictable situation for drugmakers. Pfizer, in particular, could be ...
House Republicans subpoenaed Pfizer’s former Vice President and Chief Scientific Officer of RNA and Viral Vaccines Dr. Philip Dormitzer. The House Judiciary Committee requested in May that Dormitzer ...
Parents in the United States who want to vaccinate their young children against Covid-19 may face a growing set of challenges this fall. The US Food and Drug Administration might not renew ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback